Table 4.

Individual drug-resistance frequency

Drug	Primary cases	Presumptive drug-resistant cases	Overall
RIF (Rifampicin)	7/48 (14.6%)	2/7 (28.6%)	9/55 (16.4%)
INH (Isoniazid)	9/42 (21.4%)	3/6 (50.0%)	12/48 (25.0%)
Km (Kanamycin)	1/34 (2.94%)	0/6 (0.0%)	1/40 (2.5%)
Cap (Capreomycin)	1/34 (2.94%)	0/6 (0.0%)	1/40 (2.5%)
Ak (Amikacin)	1/34 (2.94%)	0/6 (0.0%)	1/40 (2.5%)
Mox (Moxifloxacin)	5/34 (14.7%)	0/6 (0.0%)	5/40 (12.5%)
Lev (Levofloxacin)	6/34 (15.0%)	0/6 (0.0%)	6/40 (15.0%)
Lz (Linezolid)	1/15 (6.7%)	Could not be evaluated	1/15 (6.7%)
PAS (Para-amino salicylic acid)	0/15 (0.0%)	Could not be evaluated	0/15 (0.0%)
ETH (Ethionamide)	0/15 (0.0%)	Could not be evaluated	0/15 (0.0%)